Heritage Trust CO Gilead Sciences, Inc. Transaction History

Heritage Trust CO

$740 Million
Q1 2024

A detailed history of Heritage Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Heritage Trust CO holds 43,221 shares of GILD stock, worth $2.96 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

43,221

Previous 43,876 1.49%

Holding current value

$2.96 Million

Previous $3.55 Million 10.95%

% of portfolio

0.43%

Previous 0.5%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $46,884 - $57,174	-655 Reduced 1.49%	43,221 $3.17 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $19,782 - $22,434	270 Added 0.62%	43,876 $3.55 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $25,731 - $28,073	-348 Reduced 0.79%	43,606 $3.27 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $115,611 - $131,870	1,521 Added 3.58%	43,954 $3.39 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $46,677 - $67,013	749 Added 1.8%	42,433 $3.64 Million

Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $75,973 - $86,780	1,276 Added 3.16%	41,684 $2.57 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $40,519 - $45,637	-702 Reduced 1.71%	40,408 $2.5 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $35,389 - $44,346	-611 Reduced 1.46%	41,110 $2.44 Million
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $8,304 - $9,425	-128 Reduced 0.31%	41,721 $3.03 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $2,301 - $2,483	34 Added 0.08%	41,849 $2.92 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $45,634 - $49,862	719 Added 1.75%	41,815 $2.88 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $13,740 - $15,677	229 Added 0.56%	41,096 $2.66 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $124,799 - $142,203	-2,203 Reduced 5.11%	40,867 $2.38 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $37,011 - $46,535	-596 Reduced 1.36%	43,070 $2.72 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $6,944 - $8,064	-96 Reduced 0.22%	43,666 $3.36 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $13,966 - $17,889	-223 Reduced 0.51%	43,762 $3.27 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $83,556 - $91,909	-1,356 Reduced 2.99%	43,985 $2.86 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $22,503 - $24,840	-360 Reduced 0.79%	45,341 $2.87 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $59,952 - $67,229	-969 Reduced 2.08%	45,701 $3.09 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $167,392 - $187,523	-2,677 Reduced 5.42%	46,670 $3.03 Million
Q4 2018 Jan 18, 2019	SELL	$60.54 - $79.0 $14,529 - $18,960	-240 Reduced 0.48%	49,347 $3.09 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $19,673 - $21,781	-276 Reduced 0.55%	49,587 $3.83 Million
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $11,029 - $12,865	170 Added 0.34%	49,863 $3.53 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $2,039 - $2,486	28 Added 0.06%	49,693 $3.75 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $72,074 - $84,605	-1,013 Reduced 2.0%	49,665 $3.56 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.65 Million - $4.33 Million	50,678	50,678 $4.11 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Trust CO with notifications on news.

Account

Heritage Trust CO Gilead Sciences, Inc. Transaction History